XML 62 R12.htm IDEA: XBRL DOCUMENT v3.20.1
Note 5 - Stock-based Compensation; Changes in Equity
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
Note
5
- Stock-Based Compensation; Changes in Equity
 
The Company has adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic
718
which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the condensed consolidated financial statements based on their grant-date fair values.
 
The Company has applied the Black-Scholes model to value stock-based awards and issued warrants related to notes payable. That model incorporates various assumptions in the valuation of stock-based awards relating to the risk-free rate of interest to be applied, the estimated dividend yield and expected volatility of our common stock. The risk-free rate of interest is the related U.S. Treasury yield curve for periods within the expected term of the option at the time of grant. The dividend yield on our common stock is estimated to be
0%
,
as the Company did
not
issue dividends during
2019
and
2018.
The expected volatility is based on historical volatility of the Company’s common stock.
 
The Company’s net loss for the
three
months ended
September 30, 2019
and net loss for the
three
months ended
September 30, 2018
includes approximately
$20,000
and
$34,000,
respectively, of compensation costs related to share based payments. The Company’s net loss for the
nine
months ended
September 30, 2019
and
2018
includes approximately
$72,000
and
$139,000
respectively, of compensation costs related to share based payments. As of
September 30, 2019,
there was
$118,000
of unrecognized compensation expense related to non-vested stock option grants and stock grants. We expect approximately
$18,000
of additional stock-based compensation expense to be recognized over the remainder of
2019,
and
$56,000
to be recognized during
2020.
 
On
April 10, 2009,
the Board of Directors approved for adoption, and on
June 5, 2009,
the shareholders of the Corporation approved, a
2009
Stock Incentive Plan (
“2009
Plan”). The
2009
Plan and subsequent awards categorized as inducement of employment authorized the issuance of up to
510,000
shares of stock or options to purchase stock of the Company (including cancelled shares reissued under the plan.) On
June 8, 2018,
our shareholders approved the
2018
Stock Incentive Plan (
“2018
Plan”). The
2018
Plan authorizes the issuance of up to
300,000
shares of our common stock in the form of equity-based awards. Because
no
registration on Form S-
8
was filed for these additional shares within
12
months of approval by our shareholders, those additional shares are
not
available for issuance in the normal course. As of
September 30, 2019,
options for
471,144
shares remain outstanding.
 
A summary of the Company’s stock option activity, which includes grants of restricted stock, non-qualified stock options, incentive stock options, warrants and related information, is as follows:
 
   
Shares under Option
   
Weighted Average Exercise Price
 
Balance at December 31, 2018
   
471,144
    $
3.95
 
Granted
   
-
     
-
 
Cancelled/Expired
   
-
     
-
 
Exercised/Issued
   
-
     
-
 
Outstanding at September 30, 2019
   
471,144
    $
3.95
 
                 
Exercisable at September 30, 2019
   
165,264
    $
4.05
 
 
The instruments above have an aggregate intrinsic value of
$83,000,
which represents the total pre-tax intrinsic value (the difference between the closing price of the Company’s common stock on the last trading day of the quarter ended
September 30, 2019
and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all the holders exercised their options on
September 30, 2019.